|
Busy As Beavers; Three
Marijuana Legalization Initiatives Active in Oregon |
|||
by Phillip
Smith for Drug War
Chronicle » Issue #698
- August 24, 2011: Activists in Oregon are serious about legalizing
marijuana. There are currently three different marijuana legalization
initiative campaigns aimed at the November 2012 ballot underway there and,
this year, there are signs the state's fractious marijuana community is going
to try to overcome sectarian differences and unify so that the overarching
goal -- freeing the weed -- can be attained. The three initiatives are in varying stages
of advancement, with one already engaged in signature-gathering, one just
approved for a ballot title, and the third trying to obtain the 1,000
signatures necessary to be granted a ballot title and be approved for signature-gathering. The initiative currently furthest down the
path toward the ballot box, is the Oregon Cannabis Tax Act of 2012 (Initiative Petition #9),
sponsored by veteran activist and medical marijuana <continued
on page 3 > |
President Balks At Responding To Medical Marijuana Question
At Town Hall
Cannon
Falls, MN, USA: President
Barack Obama this week refused to offer a substantive reply to an audience
member's question regarding the administration's failure to take steps to
allow for the physician-recommended use of marijuana. During a Town Hall event on Monday the President
was asked: "If you can't legalize marijuana, why can't we just legalize
medical marijuana, to help the people that need it?" Obama responded:
"Well, you know, a lot of states are making decisions about medical
marijuana. As a controlled substance, the issue then is, you know, is it
being prescribed by a doctor, as opposed to, you know
-- well -- I'll -- I'll -- I'll -- I'll leave it at that." <continued
on page 4 > |
Israel: Government Officially Recognizes Therapeutic Value Of
Cannabis -- Codifies Regulations For Producing, Providing It To Patients
Tel Aviv, Israel: The Israeli government on Sunday acknowledged the therapeutic utility of cannabis and
announced newly amended guidelines governing the state-sponsored production
and distribution of medical cannabis to Israeli patients. A prepared statement posted Monday on the website of office
of the Israeli Prime Minister states: "The Cabinet today approved
arrangements and supervision regarding the supply of cannabis for medical and
research uses. This is in recognition that the medical use of cannabis is necessary
in certain cases. The Health Ministry will -- in coordination with the Israel
Police and the Israel Anti- <continued
on page 5 > |
|
|
* Volume 8, Issue 9 * September * 2011
* www.MercyCenters.org *
|
||
* The MERCY News * |
|
_____________________ The MERCY News Report is an
all-volunteer, not-for-profit project to record and broadcast news,
announcements and information about medical cannabis in Oregon, across
America and around the World. For more information about the MERCY News, contact us. Via
Snail Mail: The MERCY
News 1469 Capital
St. NE, Suite 100, Salem, Ore.,
97301 503.363-4588 E-mail: Mercy_Salem@hotmail.com Or
our WWW page: www.MercyCenters.org Check it
out! ___________________________ MERCY On The Tube! in Salem, Oregon area thru Capital Community
Television, Channel 23. See
us on Wednesdays at 06:30pm, Thursdays at 07:00pm, Fridays at 10:30pm and
Saturdays at 06:00pm. Visit – http://mercycenters.org/tv/ |
About
MERCY – The Medical Cannabis Resource Center MERCY is a non-profit, grass roots organization
founded by patients, their friends and family and other compassionate and
concerned citizens in the area and is dedicated to helping and advocating for
those involved with the Oregon Medical Marijuana Program (OMMP). MERCY is based in the
Salem, Oregon area and staffed on a volunteer basis. The
purpose is to get medicine to patients in the short-term while working with
them to establish their own independent sources. To
this end we provide, among other things, ongoing education to people and
groups organizing clinics and other Patient Resources, individual physicians
and other healthcare providers about the OMMP, cannabis as medicine and
doctor rights in general. The mission of the organization
is to help people and change the laws. We advocate reasonable, fair and effective
marijuana laws and policies, and strive to educate, register and empower
voters to implement such policies. Our philosophy is one of teaching
people to fish, rather than being dependent upon others. Want to get your Card? Need Medicine Now? Welcome to The Club! MERCY – the Medical Cannabis Resource Center
hosts Mercy Club Meetings every Wednesday at - 1469 Capital
Street NE, Suite #130, Salem, 97301 – from 7pm to 9pm to
help folks get their card, network patients to medicine, assist in finding a
grower or getting to grow themselves, or ways and means to medicate along
other info and resources depending on the issue. visit – www.MercyCenters.org
- or Call 503.363-4588 for more. The Doctor is In ... Salem! * MERCY is Educating Doctors on signing for their
Patients; Referring people to Medical Cannabis Consultations when their
regular care physician won't sign for them; and listing all Clinics around
the state in order to help folks Qualify for the OMMP and otherwise Get their
Cards. For our Referral Doc in Salem,
get your records to – 1469 Capital Street NE, Suite
#100, Salem, 97301, NOTE: There is a $25 non-refundable deposit
required. Transportation and Delivery
Services available for those in need.
For our Physician Packet to educate your Doctor, or a List of Clinics
around the state, visit – www.MercyCenters.org
- or Call 503.363-4588 for more. Other Medical Cannabis Resource NetWork
Opportunities for Patients as well as CardHolders-to-be. * whether Social meeting, Open to public
–or- Cardholders Only * visit: http://mercycenters.org/events/Meets.html
! Also Forums - a means to
communicate and network on medical cannabis in Portland across Oregon and
around the world. A list of
Forums, Chat Rooms, Bulletin Boards and other Online Resources for the Medical
Cannabis Patient, CareGiver, Family Member, Patient-to-Be and Other
Interested Parties. * Resources > Patients (plus) > Online
> Forums * Know any? Let everybody else know!
Visit: http://mercycenters.org/orgs/Forums.html and Post It! |
2 mercycenter@hotmail.com * |
Volume 8, Issue 9 *
September * 2011 |
|
||
|
<continued from OREGON INITIATIVEs, page 1 > entrepreneur Paul Stanford. It would allow adult Oregonians to possess
and grow their own marijuana. It would allow Oregon farmers to grow hemp. And
it would license Oregon farmers to grow marijuana to be sold at
state-licensed pot stores. An earlier version of OCTA failed to make the
ballot last year OCTA has been approved for
signature-gathering, and OCTA spokespersons said it had so far collected more
than 30,000 signatures. It needs some 87,000 valid voter signatures to make
the ballot, so OCTA's goal is to gather about 130,000 to have a comfortable
cushion to account for invalid signatures. The initiative next in line is a proposed constitutional
amendment (Initiative Petition #24) to repeal the state's marijuana laws
sponsored by the Oregon
Marijuana Policy Initiative, which is supported by numerous in-state
groups. "Except for actions that endanger minors or public safety,
neither the criminal offenses and sanctions nor the laws of civil seizure and
forfeiture of this state shall apply to the private personal use, possession
or production of marijuana by adults 21 years of age and older," the
amendment says. "The State may enact laws and regulations consistent
with this amendment to reasonably define, limit and regulate the use,
possession, production, sale or taxation of marijuana under state law." Because it is a constitutional amendment and
not an initiative, the OMPI must climb a higher hurdle to qualify for the
ballot. Instead of 87,000 valid signatures, it needs 114,000. The initiative still in the initial phase of qualifying for a
ballot title is from Sensible
Oregon, a coalition formed this year that includes Oregon NORML and a variety
of other groups. The Sensible Oregon initiative "would remove existing
civil and criminal penalties for adults twenty one years of age, who
cultivate, possess, transport, exchange or use marijuana" and require
the legislature to come up with a regulatory scheme. The Sensible Oregon initiative has gathered
about 400 of the initial 1,000 needed to win a |
ballot title. Activists
are gathering them on a volunteer basis. "We don’t have any paid petitioners;
we're working strictly as volunteers," said Oregon NORML board member
and Sensible Oregon spokesperson Anna Diaz, who added that it is difficult to
obtain funding at this early stage. "When we talk to various funding
sources, we need to wait for the ballot title before anyone will take us very
seriously. Once we do that, our hope is that we can go after some big
funding." Funding is also an issue for the OCTA
campaign, said campaign spokesperson Jennifer Alexander. "We had to stop
our signature gathering effort because we need to do some major
fundraising," she said. "We have some volunteers, but we're trying
to raise about $150,000 to fund the rest of the signature drive. If we can
raise the money, we can do it in eight or ten weeks." OCTA will be the initiative "most accepted
by the public," Alexander said. "It also addresses hemp, which
would be a huge economic and environmental boon to the Oregon economy, and it
provides the regulatory structure that Oregonians are most familiar with,
similar to how we handle alcohol. You can grow your own or you can buy it
from the store, and the money goes back to the state, which generates revenue
and a regulated environment." Last year, Oregon NORML supported OCTA, but it is
going down a different path this year. "Paul Stanford has been trying to
pass some form of OCTA for about 20 years, and we didn't want to do the same
thing and get the same results," said Diaz. "At the same time, the Sensible Washington people had
come forward with the idea of removing all criminal penalties, and we decided
that would be more appealing to voters and a better model to attempt,"
Diaz said. "While we are not disparaging Paul or his efforts, OCTA has
just failed one too many times for us." Doug McVay, a long-time activist now (again)
working for Voter Power,
the group behind Oregon's successful 1998 medical marijuana <continued on next page> |
|
|
503.363-4588 * www.MercyCenters.org 3 |
||
* The MERCY News * |
|
||
|
<continued from previous page> initiative, said Voter Power supports any and
all of the initiatives, but is concentrating its limited resources on the
OMPI constitutional amendment and a second initiative that would create a
state-regulated medical marijuana dispensary system. "In Oregon, we have three chances to
make history, and that's exciting," he said. "All of them or any of
them could create a ripple, hell, a tidal wave across the country. I will be
working to help them make the ballot and working to make their passage a
reality." Factionalism
and in-fighting has been the bane of the marijuana movement in Oregon, as in
so many other places, but this time around, there is a lot of talk about
unity and supporting whatever will work. "We
will get behind other initiatives if ours doesn't work out," said Diaz.
"There is also talk about all three initiatives doing polling to see
which would really fly, and all of us jumping on that. Surprisingly, this is
one time where I'm hearing proponents of every proposed initiative suggesting
we should all support each other. It's not a matter of competing against each
other." "We're all trying to end prohibition and
these are just different models to do so," said OCTA's Alexander.
"I love that we have so many going to the ballot. We have all pretty
much agreed that whichever one makes the ballot, we will support it. There
have been a lot of people picking apart the different initiatives, but we
have to get behind each other and work for the common goal." That would be a very good thing. A marijuana
movement unified around a legalization initiative would be able to
concentrate on real opposing forces instead of having to defend itself from
sniping from within. We don't want to see a repeat of last year's experience
in California, where "Stoners against Prop 19" types had initiative
organizers looking over their shoulders to fend off attacks from within the
ranks even as they tried to confront the organized opposition. SOURCE: http://stopthedrugwar.org/chronicle/2011/aug/24/three_marijuana_legalization_ini |
<continued
from PRESIDENT BALKS, page 1 > In July, the
administration issued a revised
memorandum to US Attorneys stating that it opposes any production or
distribution of marijuana as a medicine, even when such activities are in
compliance with state
law. President Obama had offered similarly vague
responses to questions regarding marijuana policy at other Town Hall forums.
At a town meeting in 2009, Obama curtly rejected
the proposition that legalizing and regulating cannabis could "boost the
economy and reduce drug cartel related violence," stating, "The
answer is no, I don't think that [is] a good strategy." When Obama's former press secretary Robert Gibbs
was later asked to elaborate on the President's
position, he responded:
"Uh, he, he does not think that, uh, uh, that that is uh, uh,
[pause] he opposes it, he doesn't think that that's the, the right plan for
America." Prior to Obama's ascension to the Presidency, he espoused
decriminalizing the possession of marijuana. Commenting on the President's most recent
response, NORML Deputy Director Paul Armentano said, "If the President of the United States can't
publicly articulate why we continue to arrest over one-half million Americans each year for possessing
marijuana, then why are we as a nation continuing to engage in this
destructive and illogical policy?" The full video of Monday's Town Hall forum is
available online at: http://www.youtube.com/watch?v=ZOZji2w-i30. The question
from the audience pertaining to medical cannabis and Obama's response is at
the 49-minute mark. For more information, please contact Allen St.
Pierre, NORML Executive Director, at (202) 483-5500 or Paul Armentano, NORML
Deputy Director, at: paul@norml.org _____________________________________________________________ <continued
from ISRAEL, page 1 > . Drug Authority -- oversee the foregoing and will
also be responsible for supplies from imports and local cultivation." According
to the Israeli online news site Haaretz, approximately 6,000 Israeli <continued on next page> |
|
4 mercycenter@hotmail.com * |
|
||
Volume 8, Issue 9 *
September * 2011 |
|
||
|
<continued from previous page> patients are supplied with locally grown cannabis as part of a
limited government program. This week's announcement indicates that
government officials intend to expand the program to more patients and
centralize the drug's supply. "[T]here are predictions that doctor and
patient satisfaction is so high that the number could reach 40,000 in
2016," The Jerusalem Post reports. The Israeli Ministry of Health is expected to oversee
the production of marijuana in January 2012. Similar government-sponsored medical marijuana
programs are also active in Canada
and the Netherlands. By contrast, in July the United States Drug
Enforcement Administration (DEA) formally denied a
nine-year-old petition calling on the agency to initiate hearings to reassess
the present classification of marijuana as a schedule I controlled substance, stating in the July 8, 2011 edition of the Federal
Register that cannabis has "a high potential for abuse; ... no currently
accepted medical use in treatment in the United States; ... [and] lacks
accepted safety for use under medical supervision." For more
information, please contact Allen St. Pierre, NORML Executive Director, at
(202) 483-5500, or Paul Armentano, NORML Deputy Director, at: paul@norml.org. _____________________________________________________________ Cannabis
Use Common Among Patients With Inflammatory Bowel Disease, Study Says
Toronto, Canada: The use of cannabis is common among patients
with inflammatory bowel disease (IBD), according to survey
data to be published in the European Journal of Gastroenterology and
Hepatology. An international team of researchers from Mount
Sinai Hospital in Toronto and the Salford Royal NHS Foundation Trust in the
United Kingdom surveyed one hundred patients with ulcerative colitis (UC) and
191 patients with Crohn's disease (CD) attending a tertiary-care outpatient
clinic. |
A comparable proportion of patients with
ulcerative colitis and Crohn's disease reported lifetime (51 per cent and 48
per cent) or current (12 per cent and 16 per cent) cannabis use, investigators
reported. Of lifetime users, 33 per cent of patients with colitis ulcerosa and
50 per cent of patients with Crohn's disease acknowledged having used the
substance to mitigate
symptoms related to inflammatory bowel disease, including abdominal pain,
diarrhea and reduced appetite.Authors concluded: "Cannabis use is common
amongst patients with IBD for symptom relief, particularly amongst those with
a history of abdominal surgery, chronic abdominal pain and/or a low quality
of life index. The therapeutic benefits of cannabinoid derivatives in IBD may
warrant further exploration." According to the US government website
clinicaltrials.gov, investigators at the Meir University Center in Israel are presently conducting a double blind,
placebo-controlled clinical trial to evaluate the effect of cannabis
inhalation on patients with IBD. For more information, please contact
Paul Armentano, NORML Deputy Director, at: paul@norml.org. Full text of
the study appears online in the European Journal of Gastroenterology and
Hepatology. _____________________________________________________________ Synthetic THC Reduces Motility In Patients With Irritable Bowel
Syndrome
Rochester, MN, USA: The administration of
synthetic THC (aka dronabinol) decreases colonic motility compared to placebo
in patients with irritable bowel syndrome (IBS), according to clinical
trial data to be published in the journal Gastroenterology. Investigators at the Clinical Enteric
Neuroscience Translational and Epidemiological Research (CENTER) in
Rochester, Minnesota assessed the impact of oral THC versus placebo in a
randomized trial of 75 patients with IBS. Researchers reported that active THC decreased
motility of the large intestine during <continued on next page> |
|
|
503.363-4588 * www.MercyCenters.org 5 |
||
* The MERCY News * |
|
||
|
<continued from previous page> fasting compared to placebo in all of the study's
participants. Dronabinol administration yielded the most significant
results in IBS patients with diarrhea and in subjects with alternating
diarrhea and constipation. "[D]ronabinol may provide potential benefit
to those [IBS patients] with accelerated transit," researchers
concluded. Dronabinol is presently a schedule III controlled
substance. It is approved by the US Food and Drug Administration for the
treatment of severe nausea and cachexia (wasting syndrome). Irritable bowel syndrome (IBS) refers to a
disorder that involves abdominal pain and cramping, as well as changes in
bowel movements. It is a different condition than inflammatory bowel disease
(IBD), which includes Crohn's disease and ulcerative colitis. Earlier this month, survey results
published online in the European Journal of Gastroenterology and
Hepatology reported that patients with IBD commonly use cannabis
therapeutically. For more information, please contact Paul Armentano,
NORML Deputy Director, at: paul@norml.org. Full text of
the study, "Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced
Fasting Colonic Motility in Patients with Non-Constipated Irritable Bowel
Syndrome," will appear in Gastroenterology. _____________________________________________________________
Medi-Pot Most Often Consumed For Pain, Muscle Spasms, Study Says
"These data suggest that the patient
population has evolved from mostly HIV/AIDS and cancer patients to a
significantly more diverse array" Santa Cruz, CA, USA: Patients in California
with a physician's recommendation are predominantly using cannabis to treat
symptoms of pain,
insomnia, and anxiety, according to population data published in the present
issue of the Journal of Psychoactive Drugs. Researchers at the University of California, Santa Cruz analyzed data from 1,746 |
consecutive admissions to nine medical marijuana assessment clinics
operating throughout California. Authors reported, "[R]elief of pain, spasms,
headache, and anxiety, as well as to improve sleep and relaxation were the
most common reasons patients cited for using medical marijuana."
Patients typically reported that cannabis provided them with more than one
therapeutic benefit, and four in five (79.3 percent) reported having first
tried other medications prescribed by their physicians, almost half of which
were opiates. Of those sampled, three-fourths of the patients
were male and three-fifths were Caucasian. Compared to the US Census of
California, the patients in this sample were on average "somewhat
younger, report[ed] slightly more years of formal education, and [were] more
often employed." Two-fifths of patients in the sample "had not been
using marijuana recreationally prior to trying it for medicinal
purposes." Investigators also reported that patients' use of
tobacco was "somewhat higher than in the general population, but [that
their] prevalence of alcohol use was significantly lower" than that of
the general population. Patients use of other illicit substances, including
cocaine, methamphetamine, and heroin was also lower than that of the general
population. Over 80 percent of the patients in the sample reported
consuming cannabis via inhalation (86.1 percent). Twenty-five percent of
patients sampled consumed cannabis orally. Twenty-two percent vaporized cannabis and
approximately three percent said that they used the substance topically. Most patients (40.1 percent) reported consuming
up to three grams of cannabis per week. Thirty-six percent of patients
reported using four to seven grams of cannabis, and 23.3 percent said they
consumed more than seven grams of marijuana per week. A majority of
respondents (56.1 percent) said they used cannabis prior to sleep. Authors concluded: "Compared to earlier <continued on next page> |
|
6 mercycenter@hotmail.com * |
|
||
Volume 8, Issue 9 *
September * 2011 |
|
||
|
<continued from previous page> studies of medical marijuana patients, these data
suggest that the patient population has evolved from mostly HIV/AIDS and
cancer patients to a significantly more diverse array. ... This suggests that
the patient population is likely to continue evolving as new patients and
physicians discover the therapeutic uses of cannabis. "For more
information, please contact Paul Armentano, NORML Deputy Director, at: paul@norml.org.
Full text of the study, "Who are medical marijuana patients? Population
characteristics from nine California assessment clinics," appears in The
Journal of Psychoactive Drugs. _____________________________________________________________ Intravenous Administration Of THC Not Associated With 'Serious
Adverse Events' In Human Subjects
West Haven, CT, USA: The intravenous
administration of cannabis' primary psychoactive compound, delta-9-THC, poses
a "relatively low" risk to subjects' health, according to a review
of clinical trial data to be published in the journal Psychopharmacology. A team of investigators at the West Haven,
Connecticut branch of the US Department of Veteran Affairs conducted a review
of all intravenous THC studies conducted at the center over a 13-year period.
They assessed 11 studies involving 266 subjects (14 schizophrenia patients
and 252 healthy subjects, of whom 76 were frequent cannabis users), 351
active THC infusions, and 226 placebo infusions. Study subjects were monitored
for subjective and physical adverse events and followed up to 12months beyond
study participation. Authors reported: "There was one serious and
70 minor adverse events in 9.7 percent of subjects and 7.4 percent of infusions,
with 8.5 percent occurring after the end of the test day. Nausea and
dizziness were the most frequent side effects associated with intravenous THC
administration. Adverse events were more likely to be associated with faster
infusion rates (two to fiveminutes) and higher doses. Of [the] 149 subjects
on whom long-term follow-up data were gathered, 94 percent reported either no
|
change or a reduction in their desire to use cannabis
in the post-study period, 18 percent stated that their cannabis use decreased,
and three percent stated that it increased in the post-study period." Researchers concluded: "With careful subject
selection and screening, risk to subjects is relatively low. Safeguards are
generally sufficient and effective, reducing both the duration and severity
of adverse events." Commenting
on the study, NORML Deputy Director Paul Armentano said, "This review
once again reaffirms the cannabis is relatively safe, if not safer, than
comparable conventional medications or intoxicants. The plant's relatively
low toxicity and risk to health in no way justifies the continued
criminalization and arrest of hundreds of thousands of cannabis consumers
annually." For more information, please contact Paul Armentano,
NORML Deputy Director, at: paul@norml.org. Full text of
the study, "The safety of studies with intravenous
delta-9-tetrahydrocannabinol in humans, with case histories," appears
online in the journal Psychopharmacology. _____________________________________________________________ Medical Marijuana Inc. Posts Loss Despite Revenue
Jump Medical Marijuana Inc. posted a $1.29 million net loss for the second
quarter, according to a filing on the OTC Markets website, which had
different information than a press release issued by the San Diego-based
company. Total income, including relief of
indebtedness, was $377,643, according to Medical Marijuana's financial
statement filed last Friday. Expenses were reported at $1.67 million. Publicly traded Medical Marijuana said in
a statement today that its quarterly revenue increased to $184,234 from
$20,425 in the first quarter. The increase was due to new product
pre-launches in conjunction with its CannaBANK business, the
company said. <continued on next page> |
|
|
503.363-4588 * www.MercyCenters.org 7 |
||
|
|
||
|
<continued from previous
page> While the company said in its
statement that its total assets increased from $74,346 at the close of the
previous quarter to $572,255, its filing said its assets at the end of the
second quarter totaled $568,116. Medical Marijuana said in the statement
that it reduced its liabilities from $207,158 in the first quarter to
$91,370. But its filing said that total liabilities as of June 30 were
$103,464. Medical
Marijuana shares were priced at about 4.5 cents today, which OTC Markets
warned was from "unsolicited" customer orders. Unsolicited orders
can indicate that investors may have trouble selling the stock.
SOURCE: http://www.mjbusinessreport.com/wires/article.cfm?title=Medical-Marijuana-Posts-Loss-Despite-Revenue-Jump&id=eqnigkzhqtyrsww _____________________________________________________________ Michigan AG Says Prosecutors Can Close
Dispensaries Michigan Attorney General Bill Schuette
said he will be telling the state's 83 county prosecutors they can shut down
dispensaries as a result of an appellate court ruling this week. On Tuesday, a three-judge panel of the
Michigan Court of Appeals ruled that the state's medical marijuana law,
approved by voters in 2008, does not allow for patient-to-patient sales. The
ruling reversed a lower court's decision to deny Isabella County Prosecuting
Attorney Larry Burdick's request for an injunction against club Compassionate
Apothecary in Mount Pleasant. Schuette had joined in the appeal
supporting the county prosecutor. Schuette said in a statement yesterday
that the court "echoed the concerns of law enforcement, clarifying that
this law is narrowly focused to help the seriously ill, not the creation of a
marijuana free-for-all."
SOURCE: http://www.mjbusinessreport.com/wires/article.cfm?title=Michigan-AG-Prosecutors-Can-Close-Dispensaries&id=eciqfvkxotwwkgo |
Two Plead Guilty From Montana Dispensary Raids,
Report Says Two men who were arrested as a result of
large-scale law enforcement raids of Montana dispensaries in March have
pleaded guilty to federal charges, the Billings Gazette reported. Ryan Gifford Blindheim, 35, yesterday
pleaded guilty to conspiracy to manufacture marijuana and money laundering in
U.S. District Court in Missoula, the article said. Blindheim owned the Black
Pearl dispensary in Olney. Evan James Corum, 25, pleaded guilty to a
single count of money laundering. Blindheim and Corum allegedly transformed a warehouse on U.S. Highway 93 near Olney into a grow facility where law enforcement seized 488 plants and 70 pounds of bulk marijuana on March 14, the Billings Gazette said. SOURCE: http://www.mjbusinessreport.com/wires/article.cfm?title=Two-Plead-Guilty-Montana-Dispensary-Raids-Report&id=ouqizqkdprjowjv _____________________________________________________________ Boulder, Colorado, Approves 48 MMJ Businesses Boulder, Colo., city officials have
approved 48 of 120 license applications for medical marijuana businesses, the
city said. The city has denied 33 of the
applications it has received since last summer, according to a statement.
Nine applicants have withdrawn and 30 are still pending. Twenty-two of the denied businesses
have appealed and can remain open while their cases are pending. The
city said it will begin inspecting those businesses with pending appeals to
make sure they are complying with city codes to "prevent potential
continued unsafe operation and to encourage equal treatment of all
businesses." SOURCE: http://www.mjbusinessreport.com/wires/article.cfm?title=Boulder-Colo-Approves-48-MMJ-Businesses&id=airvfekueeudpse |
|
|
* The MERCY News
>
mercycenter@hotmail.com > (503)
363-4588 <
www.MercyCenters.org * |
||